(BRZU) Direxion Daily MSCI Brazil - Overview
Etf: Leveraged, Brazil, Equity, ETF
Dividends
| Dividend Yield | 2.70% |
| Yield on Cost 5y | 2.21% |
| Yield CAGR 5y | -17.85% |
| Payout Consistency | 57.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.1% |
| Relative Tail Risk | -0.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 97.19 |
| Character TTM | |
|---|---|
| Beta | 1.265 |
| Beta Downside | 1.116 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.25% |
| CAGR/Max DD | 0.39 |
Description: BRZU Direxion Daily MSCI Brazil January 20, 2026
The Direxion Daily MSCI Brazil Bull 2X Shares (BRZU) seeks to deliver twice the daily performance of the MSCI Brazil Index, which captures roughly 85 % of Brazil’s free-float-adjusted market cap across large- and mid-cap stocks.
BRZU achieves this 2× exposure primarily through derivatives-swap agreements, futures, and ETFs that track the underlying index-so at least 80 % of its net assets are allocated to these financial instruments. Because the fund is non-diversified, its performance is heavily tied to the index’s sector composition, which is dominated by financials, commodities, and energy.
Key macro drivers to watch include Brazil’s real-GDP growth (forecast ~2.3 % YoY for 2024), commodity price trends (iron ore, oil, and soy), and the Central Bank of Brazil’s policy rate (Selic) which has been hovering around 10.75 % after recent tightening cycles. The Brazilian real’s recent 5 % depreciation against the USD also adds currency risk to leveraged exposure.
Investors should remember that the 2× leverage is reset daily; over longer horizons, compounding can cause returns to diverge significantly from twice the index’s cumulative performance, especially in volatile markets.
For a deeper, data-driven assessment of BRZU’s risk-adjusted return profile, you may find ValueRay’s quantitative dashboards useful.
What is the price of BRZU shares?
Over the past week, the price has changed by +2.50%, over one month by +27.04%, over three months by +42.57% and over the past year by +110.18%.
Is BRZU a buy, sell or hold?
What are the forecasts/targets for the BRZU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 128.6 | 17.2% |
BRZU Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 137.1m USD (137.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 137.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 137.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.58% (E(137.1m)/V(137.1m) * Re(10.58%) + (debt-free company))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)